Inhibikase Therapeutics (IKT) Other Working Capital Changes (2020 - 2026)
Inhibikase Therapeutics (IKT) reported Other Working Capital Changes of -$358,875 for Q2 2026, compared with -$139,351 a year earlier.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inhibikase Therapeutics' Other Working Capital Changes came in at -$14,741; for FY2025, it came in at -$532,732.
- By year, Other Working Capital Changes came in at $616,523 in FY2024 (+455.1%), $111,068 in FY2023, -$1.34 million in FY2022 and -$2.33 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Other Working Capital Changes since Q2 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at $949,439 (Q1 2026), -$275,411 (Q4 2025) and -$329,894 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.02 Bn | 1,100.60 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.16 Bn | 531.69 Bn | 17.26 Bn |
| 3 | AbbVie | 503.74 Bn | 476.85 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.66 Bn | 261.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.30 Bn | 234.99 Bn | 12.86 Bn |
| 7 | Amgen | 236.04 Bn | 191.44 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.96 Bn | 165.16 Bn | 6.22 Bn |
| 9 | Pfizer | 169.89 Bn | 116.53 Bn | 10.94 Bn |
| 10 | Inhibikase Therapeutics | 301.14 Mn | -284.34 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.56 Mn |
| Mar 31, 2026 | -522,994.00 |
| Dec 31, 2025 | -553,224.00 |
| Sep 30, 2025 | -876,803.00 |
| Jun 30, 2025 | 136,097.00 |
| Mar 31, 2025 | -180,064.00 |
| Dec 31, 2024 | -583,280.00 |
| Sep 30, 2024 | 166,017.00 |
| Jun 30, 2024 | -51,478.00 |
| Mar 31, 2024 | -362.00 |
| Dec 31, 2023 | 282,412.00 |
| Sep 30, 2023 | 250,941.00 |
| Jun 30, 2023 | 877,643.00 |
| Mar 31, 2023 | -563,928.00 |
| Dec 31, 2022 | 105,396.00 |
| Sep 30, 2022 | 292,191.00 |
| Jun 30, 2022 | 23,522.00 |
| Mar 31, 2022 | -120,648.00 |
| Dec 31, 2021 | -803,956.00 |
| Sep 30, 2021 | 844,354.00 |
API Access
Inhibikase Therapeutics Other Working Capital Changes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-working-capital-changes", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();